GL1X · GenesisL1 explorer

Research workbench

Crystal structure of C-terminal modified tau peptide-hybrid 201D with 14-3-3SIGMA

Analyse Crystal structure of C-terminal modified tau peptide-hybrid 201D with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5HF3
Type
protein
Length
238 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
14-3-3 protein sigma; Modified tau peptide
UniProt
P31947
Ligands
ACE, 60H
Pockets
3 · best druggability 0.47

Structure

x-ray diffraction · 2 distinct chains · 78% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A14-3-3 protein sigmaprotein23180% helix, 0% strandP31947
BModified tau peptideprotein70% helix, 0% strand—

Ligands and binding sites

  • ACE · Acetyl group · ligand · chains A, B
  • 60H · (2~{S})-2-(diphenylmethyl)pyrrolidine · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1900.470.811760H
2700.370.7816empty
3520.340.7918empty

Interfaces

1 interface between chains.

  • A–B · 574 Ų buried · 8 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent, 2 modified (covalent ligand, oxidation, phosphorylation).

Compared structures

  • 5HF3 · Crystal structure of C-terminal modified Tau peptide-hybrid 201D with 14-3-3sigma · the same entry in another collection · chain A against A, TM-score 1.00
  • P31947 · AlphaFold monomer V2.0 prediction for 14-3-3 protein sigma (P31947) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.